Citation: Rm. Merrill et Dl. Weed, Measuring the public health burden of cancer in the United States through lifetime and age-conditional risk estimates, ANN EPIDEMI, 11(8), 2001, pp. 547-553
Citation: Rm. Merrill, Partitioned prostate cancer prevalence estimates: an informative measure of the disease burden, J EPIDEM C, 55(3), 2001, pp. 191-197
Citation: Rm. Merrill, Measuring the projected public health impact of lung cancer through lifetime and age-conditional risk estimates, ANN EPIDEMI, 10(2), 2000, pp. 88-96
Citation: Rm. Merrill et Be. Hankey, Monitoring progress against cancer with age-adjusted rates and trends: What role does the standard population play?, J CANCER ED, 15(2), 2000, pp. 99-107
Authors:
Merrill, RM
Capocaccia, R
Feuer, EJ
Mariotto, A
Citation: Rm. Merrill et al., Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program, INT J EPID, 29(2), 2000, pp. 197-207
Authors:
Merrill, RM
Stanford, EJ
Lindsay, GB
Neiger, BL
Citation: Rm. Merrill et al., The relationship of perceived age and sales of tobacco and alcohol to underage customers, J COMM HEAL, 25(5), 2000, pp. 401-410
Citation: Rm. Merrill et Jl. Lyon, Explaining the difference in prostate cancer mortality rates between whiteand black men in the United States, UROLOGY, 55(5), 2000, pp. 730-735
Citation: Rm. Merrill et Ra. Stephenson, Trends in mortality rates in patients with prostate cancer during the era of prostate specific antigen screening, J UROL, 163(2), 2000, pp. 503-510
Authors:
Hankey, BF
Feuer, EJ
Clegg, LX
Hayes, RB
Legler, JM
Prorok, PC
Ries, LA
Merrill, RM
Kaplan, RS
Citation: Bf. Hankey et al., Cancer surveillance series: Interpreting trends in prostate cancer - Part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates, J NAT CANC, 91(12), 1999, pp. 1017-1024
Citation: Ej. Feuer et al., Cancer surveillance series: Interpreting trends in prostate cancer - Part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality, J NAT CANC, 91(12), 1999, pp. 1025-1032
Authors:
Etzioni, R
Legler, JM
Feuer, EJ
Merrill, RM
Cronin, KA
Hankey, BF
Citation: R. Etzioni et al., Cancer surveillance series: Interpreting trends in prostate cancer - Part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality, J NAT CANC, 91(12), 1999, pp. 1033-1039
Authors:
Merrill, RM
Brown, ML
Potosky, AL
Riley, G
Taplin, SH
Barlow, W
Fireman, BH
Citation: Rm. Merrill et al., Survival and treatment for colorectal cancer medicare patients in two group staff health maintenance organizations and the fee-for-service setting, MED C RES R, 56(2), 1999, pp. 177-196
Authors:
Potosky, AL
Merrill, RM
Riley, GF
Taplin, SH
Barlow, W
Fireman, BH
Lubitz, JD
Citation: Al. Potosky et al., Prostate cancer treatment and ten-year survival among group staff HMO and fee-for-service medicare patients, HEAL SERV R, 34(2), 1999, pp. 525-546
Citation: Rm. Merrill et al., Tobacco-related cancers in Utah compared to the United-States: Quantifyingthe benefits of the 'Word of Wisdom' (On the influence and benefit of Latter-day Saint health codes), BRIGHAM YOU, 38(4), 1999, pp. 91-105
Authors:
Merrill, RM
Feuer, EJ
Warren, JL
Schussler, N
Stephenson, RA
Citation: Rm. Merrill et al., Role of transurethral resection of the prostate in population-based prostate cancer incidence rates, AM J EPIDEM, 150(8), 1999, pp. 848-860
Authors:
Legler, JM
Feuer, EJ
Potosky, AL
Merrill, RM
Kramer, BS
Citation: Jm. Legler et al., The role of prostate-specific antigen (PSA) testing patterns in the recentprostate cancer incidence decline in the United States, CANC CAUSE, 9(5), 1998, pp. 519-527